132 related articles for article (PubMed ID: 32985506)
21. Identification of prognostic and subtype-specific potential miRNAs in thymoma.
Wei J; Liu Z; Wu K; Yang D; He Y; Chen GG; Zhang J; Lin J
Epigenomics; 2017 May; 9(5):647-657. PubMed ID: 28517980
[TBL] [Abstract][Full Text] [Related]
22. [Expression and Diagnostic Value of NPTX1 in Thymoma Patients].
Du X; Yu L; Yang L; Cao D; Zhang Y
Zhongguo Fei Ai Za Zhi; 2021 Jan; 24(1):1-6. PubMed ID: 33478183
[TBL] [Abstract][Full Text] [Related]
23. Elevated serum epidermal growth factor receptor level in stage IV thymoma.
Sasaki H; Yukiue H; Sekimura A; Mizuno K; Konishi A; Yano M; Fukai I; Fujii Y
Surg Today; 2004; 34(5):477-9. PubMed ID: 15108095
[TBL] [Abstract][Full Text] [Related]
24. Expression of cathepsins V and S in thymic epithelial tumors.
Kiuchi S; Tomaru U; Ishizu A; Imagawa M; Kiuchi T; Iwasaki S; Suzuki A; Otsuka N; Deguchi T; Shimizu T; Marukawa K; Matsuno Y; Kasahara M
Hum Pathol; 2017 Feb; 60():66-74. PubMed ID: 27771373
[TBL] [Abstract][Full Text] [Related]
25. Relationship of possible biomarkers with malignancy of thymic tumors: a meta-analysis.
Zeng H; Yang W; Xu B; Zou J; Su C; Zhong B; Zhu H; Chen Z
BMC Cancer; 2020 Sep; 20(1):928. PubMed ID: 32993581
[TBL] [Abstract][Full Text] [Related]
26. Elevated serum vascular endothelial growth factor and basic fibroblast growth factor levels in patients with thymic epithelial neoplasms.
Sasaki H; Yukiue H; Kobayashi Y; Nakashima Y; Moriyama S; Kaji M; Kiriyama M; Fukai I; Yamakawa Y; Fujii Y
Surg Today; 2001; 31(11):1038-40. PubMed ID: 11766079
[TBL] [Abstract][Full Text] [Related]
27. Analysis of cell cycle regulator proteins in encapsulated thymomas.
Baldi A; Ambrogi V; Mineo D; Mellone P; Campioni M; Citro G; Mineo TC
Clin Cancer Res; 2005 Jul; 11(14):5078-83. PubMed ID: 16033820
[TBL] [Abstract][Full Text] [Related]
28. Long-term survival of a patient with type A thymoma and Masaoka's stage IV b: case report.
Takenaka T; Yano T; Kouso H; Ohba T; Kometani T; Shoji F; Maehara Y
Thorac Cardiovasc Surg; 2009 Dec; 57(8):496-7. PubMed ID: 20013628
[TBL] [Abstract][Full Text] [Related]
29. Thymic lymphoepithelioma-like carcinoma mimicking primary tumor of the lung.
Sadat K; Singh A; Rao S; Zdunek T; Malhotra R
Compr Ther; 2009; 35(2):115-9. PubMed ID: 19618760
[TBL] [Abstract][Full Text] [Related]
30. [Correlation of amplification of chromosome 1 with histologic typing of thymic epithelial tumors].
Ma YQ; Zhang C; Cui WL; Gulinaer A; Zhang W; Wang J
Zhonghua Bing Li Xue Za Zhi; 2011 Dec; 40(12):820-4. PubMed ID: 22336207
[TBL] [Abstract][Full Text] [Related]
31. [Recurrence of a stage I thymoma after resection].
Nomori H; Horio H; Iga R; Kobayashi R; Morinaga S
Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Jul; 34(7):833-6. PubMed ID: 8810768
[TBL] [Abstract][Full Text] [Related]
32. The contact length between the tumor contour and the lung on computed tomography is a risk factor for pleural recurrence after complete resection of thymoma.
Kato T; Iwano S; Taniguchi T; Kawaguchi K; Fukui T; Ishiguro F; Fukumoto K; Nakamura S; Hirakawa A; Yokoi K
Gen Thorac Cardiovasc Surg; 2015 Jun; 63(6):343-8. PubMed ID: 25663292
[TBL] [Abstract][Full Text] [Related]
33. Thymoma: radiologic-pathologic correlation.
Rosado-de-Christenson ML; Galobardes J; Moran CA
Radiographics; 1992 Jan; 12(1):151-68. PubMed ID: 1734461
[TBL] [Abstract][Full Text] [Related]
34. Tumor location may affect the clinicopathological features and prognosis of thymomas.
Tian D; Shiiya H; Sato M; Sun CB; Anraku M; Nakajima J
Thorac Cancer; 2019 Nov; 10(11):2096-2105. PubMed ID: 31499597
[TBL] [Abstract][Full Text] [Related]
35. T-cell lymphocytosis associated with lymphocyte-rich thymoma.
Barton AD
Cancer; 1997 Oct; 80(8):1409-17. PubMed ID: 9338464
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of the new TNM-staging system for thymic malignancies: impact on indication and survival.
Ried M; Eicher MM; Neu R; Sziklavari Z; Hofmann HS
World J Surg Oncol; 2017 Dec; 15(1):214. PubMed ID: 29197400
[TBL] [Abstract][Full Text] [Related]
37. DNA ploidy in thymoma and associated multiple primary malignancies in the same patient.
Sitić S; Mirt-Dabić M; Brcić L; Juros Z; Hutinec Z; Kruslin B
Acta Clin Croat; 2008 Sep; 47(3):155-9. PubMed ID: 19175064
[TBL] [Abstract][Full Text] [Related]
38. Titin, thymoma, and myasthenia gravis.
Aarli JA
Arch Neurol; 2001 Jun; 58(6):869-70. PubMed ID: 11405799
[No Abstract] [Full Text] [Related]
39. Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trial.
Thomas A; Rajan A; Berman A; Tomita Y; Brzezniak C; Lee MJ; Lee S; Ling A; Spittler AJ; Carter CA; Guha U; Wang Y; Szabo E; Meltzer P; Steinberg SM; Trepel JB; Loehrer PJ; Giaccone G
Lancet Oncol; 2015 Feb; 16(2):177-86. PubMed ID: 25592632
[TBL] [Abstract][Full Text] [Related]
40. Role of imaging in the diagnosis, staging, and treatment of thymoma.
Benveniste MF; Rosado-de-Christenson ML; Sabloff BS; Moran CA; Swisher SG; Marom EM
Radiographics; 2011; 31(7):1847-61; discussion 1861-3. PubMed ID: 22084174
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
